Document jmQBzkGq7xmwKQq467yGLOmZy

A CHEMICAL MANUFACTURERS ASSOCIATION FAX Cover Sheet To: /cVk _________ __ Company: 4 - _______________________ Telephone #: V/J ; ~ 3$Sh Fax Number /s/J 5^ "Ssv3_ From: '.<. 'SAa w*<. (7031741- s^ f Number of Pages (including cover sheet) ^ CMA 171319 mkTP The City of New York DEPARTMENT OF HEALTH Rudolph W, Qtulianl Mayor Nml l. Cohen, m.o Commissioner F. 01 NOTES/COMMENTS. rnj&uLs --1CLS cC NEW YORK CITY DEPARTMENT OP HEALTH INSTITUTIONAL REVIEW BOARD i*i BROADWAY, ROOM 707A. CN-41 NEW YORK, NY 1001J CMA 171320 nn i r' The City of New York DEPARTMENT OF HEALTH Rudolph W. Giuliani Mayor Neal L. Cohen, m.o. Commissioner INSTITUTIONAL REVIEW BOARD 346 Broadway, Run. 707A, Box 65, New York, NY 10013 (212) 442-3360; FAX (212) 442-3535 F.G2 TO: FROM: MEMORANDUM Rasmukh Shah, Ph.D., DABT CHEMSTAR Margaret Cruz, MPH Administrator Institutional Review Board SUBJECT: Annual Renewal DATE. June 22,1998 IRB#: 97058 Vital Statistics Log#95-l 17 STUDY: "An Update ofthe Epidemiologic Mortality Study ofVinyl Chloride Workers" EXPIRATION DATE: July 10,1998 This is to inform you that IRB approval for your study will expire on the date shown above. Please fill out the enclosed Annual Progress Report Form as soon as possible to avoid IRB suspension from proceeding with your project Thank you for your attention to this matter. CMA 171321 JUL-^-1998 13 = 35 HRTP The City of New York DEPARTMENT OF HEALTH Rudolph W. Giuliani Mayor Neal L. Cohen, n o. Commissioner INSTITUTIONAL REVIEW BOARD 346 Broadway, Rm. 707A. Box 65, New York, NY 10013 (212) 442-3380; FAX (212) 442-3535 Annual Progress Report to the New York City Department of Health Institutional Review Board Principal Investigator(s): Study Title: IRB Number: Submission Date of this Annual Report: Objectives of the Study: P.03 Methodology (Brief Summary): 1 CMA 171322 ,w ~>0 tiKrp Results to Date: P.04 Summary of Any Problems in the Areas of: Patient Confidentiality:____________ ,, Recruitment: Adverse Reactions: Study Subject Complaints: Other Areas Pertinent to the Protection of Human Subjects: Proposed Changes in the Study Protocol, Consent Process or in Questionnaires should be attached to this document. This report must be submitted to the NYCDOH Institutional Review Board office. Box# 65, at least 3 weeks prior to the expiration date of the study's approval. Failure to submit this report in time may result in the temporary suspension of a study's approval and a halt to the study until the next IRB meeting. Questions: Please contact Dr. Daniel Vasgird, Chairperson of the NYCDOH IRB at (212) 442-3380 or by mail at 346 Broadway, Box#65, NY, NY, 10013. TOTAL P.04 CMA 171323